TERPENE INDEX
Terpenes are the aromatic compounds a cannabis plant produces alongside its cannabinoids. They are why one cultivar smells of pine and another of citrus, and they are the basis on which we assign material to our five lines.
How much they change the experience is an open question, and we would rather say so than pretend otherwise. In 2019 a research group tested the six most common cannabis terpenes and found none of them altered cannabinoid receptor signalling; the paper is titled "Absence of Entourage". A 2025 group testing sixteen terpenes reported the opposite. A 2025 review of the whole field concluded the synergy remains unproven and that clinical trials are needed.
We formulate on terpene composition because composition is measurable and it is published on every batch. We do not claim a mechanism the literature has not settled.
Every entry below carries an evidence tier and its sources.
- Aroma
- Earthy, musky, clove.
- Character
- The most abundant terpene in modern cannabis, and the one most associated with heavier, slower profiles.
- Also found in
- Hops, lemongrass, thyme.
- Mechanism
- Studied at alpha-2 adrenoceptors and, in one model, the serotonergic pathway; a reported TRPV1 interaction did not replicate in the human channel.
- Associated line
- REST
- Evidence
- Supported
- Sources
- CITATION PENDING
- Aroma
- Pepper, clove, warm wood.
- Character
- A sesquiterpene, heavier than the citrus and pine compounds, and the only cannabis terpene with a documented claim to direct cannabinoid receptor binding.
- Also found in
- Black pepper, clove, hops.
- Mechanism
- Described as a selective CB2 receptor agonist, which is the receptor family expressed peripherally rather than in the brain; one 2019 study found no such activity, and the dispute is unresolved.
- Associated line
- RELIEF
- Evidence
- Supported
- Sources
- CITATION PENDING
- Aroma
- Lavender, floral, faint citrus.
- Character
- Light, and the compound most responsible for a profile reading as soft.
- Also found in
- Lavender, coriander, birch.
- Mechanism
- Studied at benzodiazepine-responsive GABA-A receptors. In mice the effect disappeared when the sense of smell was removed, which suggests the aroma itself is part of the route rather than a byproduct of it.
- Associated line
- RELIEF and CALM
- Evidence
- Supported
- Sources
- CITATION PENDING
- Aroma
- Pine, rosemary, sharp resin.
- Character
- Bright and volatile, among the first compounds lost when material is dried.
- Also found in
- Pine, rosemary, basil.
- Mechanism
- Binds as a partial modulator at the benzodiazepine site of the GABA-A receptor, shown by electrophysiology and molecular docking, and studied for its effect on non-REM sleep architecture.
- Associated line
- UNDER REVIEW
- Evidence
- Supported
- Sources
- CITATION PENDING
- Aroma
- Citrus peel, bright, sharp.
- Character
- The compound that makes a profile read as lifted rather than heavy.
- Also found in
- Citrus rind, juniper, peppermint.
- Mechanism
- Studied at adenosine A2A receptors, with downstream effects on dopaminergic and GABAergic signalling in the striatum, a route distinct from the GABA-A compounds above.
- Associated line
- FOCUS
- Evidence
- Supported
- Sources
- CITATION PENDING
- Aroma
- Earthy, hoppy, woody.
- Character
- A sesquiterpene that commonly co-occurs with beta-caryophyllene, its structural isomer.
- Also found in
- Hops, sage, ginseng.
- Mechanism
- Reported activity is preclinical; a 2024 scoping review exists to consolidate its early evidence base.
- Associated line
- UNASSIGNED
- Evidence
- Emerging
- Sources
- CITATION PENDING
- Aroma
- Floral, woody, bark, faint citrus.
- Character
- A sesquiterpene alcohol, and also described as a transdermal penetration enhancer, which is a formulation property.
- Also found in
- Jasmine, ginger, tea tree.
- Mechanism
- The one exception in a TRPV1 screen where the other cannabis terpenes showed no effect: nerolidol induced weak TRPV1 activation.
- Associated line
- UNASSIGNED
- Evidence
- Emerging
- Sources
- CITATION PENDING
- Aroma
- Fresh, piney, faintly floral.
- Character
- Present across chemovars; mechanistic data is sparse.
- Also found in
- Nutmeg, tea tree, apple.
- Mechanism
- UNKNOWN
- Associated line
- UNASSIGNED
- Evidence
- Emerging
- Sources
- CITATION PENDING
- Aroma
- Sweet, woody, herbaceous.
- Character
- Reported antimicrobial and antifungal activity, consistent with a plant defense role.
- Also found in
- Mint, parsley, basil.
- Mechanism
- No effect on the TRPV1 channel in the screen that tested it.
- Associated line
- UNASSIGNED
- Evidence
- Emerging
- Sources
- CITATION PENDING
- Aroma
- Floral, sweet, chamomile.
- Character
- Characteristic of fiber-type cannabis alongside beta-eudesmol, guaiol, and eucalyptol.
- Also found in
- Chamomile, candeia tree.
- Mechanism
- UNKNOWN
- Associated line
- UNASSIGNED
- Evidence
- Emerging
- Sources
- CITATION PENDING
- Aroma
- Minty, cooling, camphoraceous.
- Character
- Also known as 1,8-cineole; reported activity is preclinical.
- Also found in
- Eucalyptus, rosemary, sage.
- Mechanism
- UNKNOWN
- Associated line
- UNASSIGNED
- Evidence
- Emerging
- Sources
- CITATION PENDING
- Aroma
- Rose, sweet.
- Character
- Reported antioxidant activity is preclinical.
- Also found in
- Geranium, rose oil, lemons.
- Mechanism
- UNKNOWN
- Associated line
- UNASSIGNED
- Evidence
- Emerging
- Sources
- CITATION PENDING
- Aroma
- Camphor, cool, herbal.
- Character
- A bicyclic monoterpene documented as a positive modulator of GABA-A action at recombinant human receptors.
- Also found in
- Camphor, rosemary, mint.
- Mechanism
- Documented as a positive modulator of GABA-A action at recombinant human GABA-A receptors, the same mechanistic family as pinene and linalool.
- Associated line
- UNASSIGNED
- Evidence
- Emerging
- Sources
- CITATION PENDING
- Aroma
- Sweet, piney, cypress.
- Character
- Shares alpha-pinene’s mechanism.
- Also found in
- Pine, cedar, rosemary.
- Mechanism
- Prolonged the decay time constant of GABA-A receptors, fully blocked by flumazenil, with docking at the benzodiazepine binding site.
- Associated line
- UNASSIGNED
- Evidence
- Emerging
- Sources
- CITATION PENDING
Nearly all of the work above is preclinical. Human trials of isolated terpenes at the concentrations found in cannabis are close to nonexistent, and we would rather you knew that from us.